LoginSearch News ArchivesSearch for a SupplierCalendar of events |
Thermo Fisher Scientific Improves Cancer Diagnostics for West of Scotland Regional Cytogenetics Service
The West of Scotland Regional Cytogenetics Service provides assistance to approximately three million people in western Scotland. The postnatal laboratory is using a full range of standard cytogenetic techniques and molecular cytogenetic technology to provide comprehensive chromosome analysis for both constitutional and acquired abnormalities. The laboratory processes approximately 6,500 analyses per year: nearly 2,800 of these are postnatal referrals. With such a high turnaround, the laboratory recognized that it needed to implement automated procedures to improve reporting times, quality and success rates. Prior to installing the Thermo Scientific instrumentation, the postnatal laboratory experienced challenges with manual coverslipping and inconsistent speed in its manual banding process. The division needed an automated solution to increase throughput of blood samples, ensuring more efficient sample turnaround, slide preparation and reporting of results. Jim Colgan, principal scientist for the postnatal laboratory, explains: "We selected the Thermo Scientific instrumentation for its excellent efficiency and capability to meet even the most demanding applications. Overall, with the new instrumentation our laboratory workflows have been considerably enhanced, and throughput of blood samples has been accelerated while ensuring optimum results." For the West of Scotland Regional Cytogenetics Service, automating its procedures with the postnatal laboratory has led to a significant improvement in reporting times, quality and success rates. It has also decreased the poor quality rate for both routine and urgent blood samples. For more information about Thermo Scientific laboratory automation equipment, please call + 44 (0)800 018 9396, e-mail pathology@scottpr.com or visit www.thermo.com/pathology. Thermo Scientific is part of Thermo Fisher Scientific Inc. |
|